Neuroscience Market Release Latest Trends and Industry Vision 2026

Neuroscience Market Size, Share, Trend,
Outlook, Future Growth Analysis And
Synthesis 2018 - 2026
Neuroscience involves use of various methods to measure and image the brain activity.
Neuroscience is umbrella term focusing on molecular, cellular, developmental, structural,
functional, evolutionary, computing, psychosocial, and medical aspects of the nervous system.
Research in neuroscience is constantly evolving based on biology, pharmaceutical science,
medicine, cognitive science, and biomedical engineering. Neuroscience-based devices help in
collecting valuable information regarding activities in brain and can be used in various areas
such as better understanding of pathophysiology and symptoms of various chronic neurological
diseases such as epilepsy, Alzheimer’s disease and other dementias; cerebrovascular diseases
including stroke, migraine, and other headache disorders, multiple sclerosis, Parkinson's disease,
neuro-infections, brain tumors; and traumatic disorders of the nervous system due to head
trauma.
Request Sample of Report: https://www.coherentmarketinsights.com/insight/request-sample/2487
These devices consist of different instruments that are required for neuroscience-based
experiments. Various types of electrophysiology instruments and imaging instruments are utilized
to map the brain and examine the brain activity.
The global neuroscience market size was valued at US$ 26,593 million in 2017, and is expected
to witness a CAGR of 3.9% over the forecast period (2018 – 2026).
Increasing burden of neurological diseases worldwide is expected to be a major factor
accelerating the growth of the global neuroscience market
Increasing prevalence of various chronic neurological diseases worldwide is expected to be a
major driver for growth of the global neuroscience market. This is owing to high unmet
medical need in terms of timely diagnosis and effective treatment of neurological diseases. This
in turn requires better understanding of pathophysiology of the diseases and improvement in
knowledge about functioning of nervous system, which is expected to boost demand for
neuroscience devices.
According to World Alzheimer Report in 2016, around 46.5 million people suffered from
Alzheimer’s disease and the number was expected to reach 50 million by 2017, with a
frequency of one new patient of Alzheimer’s disease every there seconds worldwide.
According to World Health Organization (WHO) 2016 report, around 6 million deaths occur due
to stroke, annually and over 80% of these deaths take place in low- and middle-income
countries. Moreover, over 50 million people suffer from epilepsy and 47.5 million people from
dementia, with 7.7 million new cases, annually worldwide.
Increasing product launch and government funding for neuroscience research is expected to
propel the neuroscience market growth
Key players in the market are focused on launching new instruments and software components,
which address current research needs for neuroscience. This in turn is expected to boost the
market growth. For instance, in 2015, Blackrock Microsystems LLC showcased new digital,
wireless brain-interface titled — CerePlex W – at Society for Neuroscience Conference (SfN),
Washington, U.S.
Report includes chapters which deeply display the following deliverable about industry :
• Neuroscience Market Research Objective and Assumption
• Neuroscience Market Purview - Report Description, Executive Summary, and Coherent
Opportunity Map (COM)
• Neuroscience Market Dynamics, Regulations, and Trends Analysis - Market Dynamics,
Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals,
Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Neuroscience Market, By Regions
• Neuroscience Market Competition by Manufacturers including Production, Share, Revenue,
Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Neuroscience Market Manufacturers Profiles/Analysis including Company Basic Information,
Manufacturing Base and Its Competitors.
• Neuroscience Market Manufacturing Cost Analysis including Key Raw Materials and Key
Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Neuroscience Market Forecast including Production, Consumption, Import and Export Forecast
by Type, Applications and Region.
• Research Findings and Conclusion
Key players operating in the global neuroscience market include, Alpha Omega, Inc., GE
Healthcare, Axion Biosystems, Inc., Siemens Healthineers, Scientifica Ltd., Blackrock
Microsystems LLC, Femtonics Ltd., LaVision Biotec GmbH, Intan Technologies, NeuroNexus
Technologies, Inc., Newport Corporation, Neuralynx Inc., Plexon Inc., Mediso Medical Imaging
Systems, Noldus Information Technology, Sutter Instrument Corporation, Thomas Recording
GmbH, and Trifoil Imaging Inc.
Detailed Segmentation:
Global Neuroscience Market, By Component:
•Instrument
•Software
•Services
Global Neuroscience Market, By End User:
•Hospitals
•Diagnostic Laboratories
•Research Institutes
•Academic Institutes
Get Full Access of This Business Report: https://www.coherentmarketinsights.com/market-insight/
neuroscience-market-2487
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering actionready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

The global neuroscience market size was valued at US$ 26,593 million in 2017, and is expected to witness a CAGR of 3.9% By 2026.